MIB Agents Now Accepting Submissions for OutSmarting Osteosarcoma Grants
MIB Agents, a well-known nonprofit organization, is now inviting Letters of Intent (LOIs) for its annual OutSmarting Osteosarcoma research grant program. This program is designed to encourage innovative research that can significantly enhance the outcomes for patients facing osteosarcoma, an aggressive type of bone cancer that affects about 1,000 individuals each year in the U.S., with half of those being children and teenagers.
Fostering Educational and Research Development
Since its inception in 2017, the OutSmarting Osteosarcoma program has funded noteworthy research efforts, investing a total of $1.8 million across 22 investigators. Each year, MIB Agents provides substantial support through a variety of grants, including a prestigious Hero award worth $100,000, as well as a $50,000 Young Investigator Research Hope award tailored for early career researchers.
Community Engagement Enhancing Research Impact
This funding initiative heavily relies on contributions from the MIB Agents Family Funds. These funds originate from the passionate fundraising activities of osteosarcoma patients and their families, honoring both current fighters of the disease and those who have sadly lost their battles. This collaborative spirit highlights MIB Agents' dedication to merging patient experiences with scientific research, ensuring that the voices of patients resonate throughout the research process.
Collaborative Peer Review Framework
The OutSmarting Osteosarcoma grant process is unique due to its collaborative model. MIB Agents engages the scientific community alongside patient families, who serve as stakeholders in the review process. They evaluate research proposals based on their potential to impact patient outcomes, forming a comprehensive evaluation system that incorporates diverse viewpoints.
Grant Application Details and Deadlines
About MIB Agents
Frequently Asked Questions
What is the OutSmarting Osteosarcoma grant program?
The OutSmarting Osteosarcoma program is a research initiative focused on funding innovative projects that can improve the outcomes of patients with osteosarcoma.
Who can apply for the grants?
The grants are available to researchers working on osteosarcoma, including both early career investigators and more established researchers.
How much funding can be received through the grants?
A total of $100,000 is awarded through the Hero award, along with a $50,000 Young Investigator Research Hope award for newcomers in research.
When do letters of intent need to be submitted?
Letters of intent must be submitted by October 25, 2024, at 11:59 PM ET.
What does the peer review process entail?
The review process involves a committee made up of scientific experts and family fund representatives who score applications based on their potential impact on patients.
